The Community Involvement Community of Practice: A Model for Collaboration in the Field Katherine West Slevin1, Nomampondo Barnabas2, Stella Kirkendale3, Morenike Ukpong4 1Global Campaign for Microbicides, PATH, Washington, DC, USA; 2Global Campaign for Microbicides, PATH, Johannesburg, South Africa; 3Family Health International, Durham, NC, USA; 4New HIV Vaccine and Microbicide Advocacy Society, Lagos, Nigeria Background: Why is a Community Involvement Photos from the 2008 and 2009 CoP Annual Meetings Some Benefits of Community of Practice (CoP) Needed? Community Engagement1 Over the last decade, staff at many clinical trials have developed expertise on proven strategies, learnt lessons, and improved practices on community Creates a conducive environment for community- engagement in and around HIV-prevention biomedical trials. research partnerships. Sharing this expertise among research staff working for different trial networks and sponsors can: Ensures ongoing two-way information exchange, (1) reduce the learning burden on network sponsors and individual feedback, and dialogue between community and research staff; research team. (2) foster a culture of collaboration; and (3) help networks and individual trial sites optimize their community engagement efforts and, thus, enable positive environments for trials Strengthens community capacity to articulate and address to take place. their own social and development needs (in turn helping to prepare for eventual introduction and access to new HIV-prevention technologies). Methods & Results: The Community Involvement CoP Enhances scientific validity and ethical integrity To facilitate greater sharing across networks and research sites, the Global throughout the trial Campaign for Microbicides established the Community Involvement Members of the Community Involvement CoP at the 2009 Annual Meeting, Mombasa, Kenya Community of Practice (CoP). The CoP brings together community liaison 1Mobilization for Community Involvement in Microbicide Trials: A Report from a Dialogue in Southern Africa. Washington, DC: Global Campaign for Microbicides; 2004. officers and others working on community engagement at HIV-biomedical research trials. The CoP was formed in 2008 and has resulted in a monthly teleconferences (the Where CoP Members Work notes of which are distributed to all members), an online resource center for By Type of HIV Prevention Study/Organization By Geography community engagement, a members directory to facilitate intra-member networking, and two annual meetings at which learnt lessons and improved Former Microbicide practices were shared. Study Staff United States Advocacy Organizations South Africa Conclusion: A Model for Collaboration Other HIV Prevention Tanzania United Kingdom Coordinated efforts to share lessons, materials, and problem-solving strategies Studies Nigeria both within and among trial networks adds value to the quality of the HIV Vaccine Studies Kenya community-engagement efforts by HIV-prevention research teams. Until the Rwanda Zambia establishment of the CoP, this kind of synergy happened within networks, but PrEP Studies Botswana To learn more about the CoP and GCM’s community engagement work, please visit little communication occurred across networks and independent research Malawi Microbicide Studies http://www.global-campaign.org/comm-involvement.htm centers. Uganda Zimbabawe Microbicide & PrEP Studies Thailand Providing an innovative model that promotes learning and networking among 0 2 4 6 8 10 12 14 research sites and staff, the CoP serves a much needed framework to facilitate collaboration within the HIV-prevention research field.
Pages to are hidden for
"48x96 Horizontal Template - PowerPoint"Please download to view full document